From Entrepreneurship to Medical Student With Shiv Gaglani

The Cyber Business Podcast

Shiv Gaglani is the Co-founder and CEO of Osmosis, a leading medical education platform acquired by Elsevier. With a background in medicine and technology, Shiv has been at the forefront of revolutionizing medical education. He co-founded Osmosis to make learning more efficient and effective for healthcare professionals worldwide. Under his leadership, Osmosis has become a trusted resource for medical students, residents, and clinicians, offering comprehensive study tools, video lectures, and interactive content. Shiv is dedicated to leveraging technology to improve healthcare education and enhance patient care. Additionally, he's a prolific writer who has authored two educational books and contributed to renowned publications such as Forbes, Quartz, and the Annals of Internal Medicine.

In this episode…

Osmosis, a leading medical education platform, emerged from a vision to revolutionize how students learn and retain information. From its inception to its growth into a prominent player in medical education, Osmosis has been a testament to one person’s entrepreneurial spirit and dedication to improving medical training.

Where entrepreneurship meets medical education, few individuals exemplify the fusion of these disciplines as Shiv Gaglani. His story embodies ambition, innovation, and a deep commitment to transforming medical learning. As Shiv navigates his dual roles as a company leader and a full-time medical student, he brings a unique perspective to both worlds. His daily experiences provide a firsthand understanding of the challenges faced by medical students and practitioners, informing Osmosis' ongoing efforts to innovate and improve medical education.

Join Matthew Connor on The Cyber Business Podcast as he hosts Shiv Gaglani, Co-founder and CEO of Osmosis from Elsevier, to discuss his entrepreneurial journey and commitment to medical education. Shiv shares insights into Osmosis' mission and founding story, explores alternative paths to traditional incubators, and offers his vision for the future of the medical field.